SEOUL (Reuters) – South Korea on Friday said Russia’s COVID-19 vaccine CoviVac has applied for preliminary regulatory approval, the country’s drug safety ministry said in a statement.
South Korea has not yet announced plans to make any purchases of CoviVac, the ministry said.
(Reporting by Sangmi Cha. Editing by Jane Merriman)
